General Information
Version
1.0
Revision date
2019-10-28
Product name
Catapresan tablets (finished product)
Product Synonyms
Catapresan® tablets 0.075 mg, 0.1 mg, 0.15 mg, 0.2 mg and 0.3 mg tablets, Catapres® tablets 0,1 mg, 0,2mg and 0,3 mg, Catapresan® 2.5 mg/plaster, 5.0 mg/plaster, 7.5 mg/plaster, Catapresan® capsules, Dixarit®tablets, Catapres® capsules, Atensina® tablets with API: Clonidine hydrochloride
1.2.1 Relevant identified uses
Pharmaceutical
1.2.2. Uses advised against
Safety Data Sheet only for the professional user on use
Emergency telephone
+1 703-527-3887 Chemtrec 24-hours
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H332
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
Signal word
Warning
Hazard statements
H332 Harmful if inhaled.
Prevention
P261 Avoid breathing dust/ fume/ gas/ mist/ vapours/ spray. P271 Use only outdoors or in a well-ventilated area.
Response
P304 + P340 + P312 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell.
Hazardous Ingredients
Clonidine hydrochloride
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. The pharmacological effect of the medicament has to be considered (see package leaflet). This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS)
